Congressional Briefing Emphasizes Actions Necessary to Address Substance Use Disorder Crisis5/12/23 12:00 AM
FDA Approves Rexulti for Agitation Associated With Dementia Due to Alzheimer’s Disease5/11/23 12:00 AMThe U.S. Food and Drug Administration (FDA) yesterday approved the expanded use of Rexulti (brexpipr...
